From Clinical Lab Products, June 2017 issue.
Adoption of Liquid Biopsy Tests for NSCLC;
Blood-based genomic tests are improving treatment decision and start times.
By Krish Bhadra, MD, Hestia Mellert, PhD, and Gary Pestano, PhD
7 June 2017
Topics: In the News